----

|                          |
|--------------------------|
|                          |  |
| 001-10315                | 63-0860407 |
| (Commission File Number) | (IRS Employer Identification No.) |
|                     |   |

|        |
|--------|
|        |  |
| ¨ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|   |   |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|   |   |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|   |   |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

----

----

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | On March 11, 2015, the Company gave notice of, and made an irrevocable commitment for, the redemption of all the outstanding principal amount of its 8.125% Senior Notes due 2020. On March 12, 2015, the Company completed its registered public offering of $300 million aggregate principal amount of 5.125% Senior Notes due 2023 at a public offering price of 100.00% of the principal amount and will use the proceeds from this offering, along with cash on hand, to complete the redemption of the 8.125% Senior Notes due 2020 in April 2015. As a result of these transactions, the Company expects to record an approximate $21 million, or $0.12 per diluted share, loss on early extinguishment of debt in the second quarter of 2015. This loss will be offset in part by interest savings. |

|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| • | On March 22, 2015, the Company entered into an agreement to settle the lawsuit filed on August 16, 2004 by General Medicine and captioned General Medicine, P.C. v. HealthSouth Corp. Although the specific terms of this settlement agreement are confidential, HealthSouth and General Medicine agreed to dismiss with prejudice the lawsuit pending in the Circuit Court of Jefferson County, Alabama and to release all claims between the parties. In exchange for General Medicine’s release, HealthSouth agreed to pay an amount of cash that is not material to the Company. |

----

----

|                                                                              |
|------------------------------------------------------------------------------|
|                                                                              |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|                                                                         | Three Months Ended |   |   |   |   |   |   |   |   |   |   |
|                                                                         | December 31, |   | Year Ended December 31, |
|                                                                         | 2014 |   | 2013 |   | 2014 |   | 2013 |   | 2012 |   | 2011 |   | 2010 |
|                                                                         | (In Millions) |
| Net cash provided by operating activities                                    | $ | 70.2 |  |   | $ | 100.9 |  |   | $ | 444.9 |  |   | $ | 470.3 |  |   | $ | 411.5 |  |   | $ | 342.7 |  |   | $ | 331.0 |  |
| Provision for doubtful accounts                                              | (6.6 | ) |   | (3.6 | ) |   | (31.6 | ) |   | (26.0 | ) |   | (27.0 | ) |   | (21.0 | ) |   | (16.4 | ) |
| Professional fees—accounting, tax, and legal                           | 1.7 |  |   | 1.7 |  |   | 9.3 |  |   | 9.5 |  |   | 16.1 |  |   | 21.0 |  |   | 17.2 |  |
| Interest expense and amortization of debt discounts and fees                 | 25.7 |  |   | 26.5 |  |   | 109.2 |  |   | 100.4 |  |   | 94.1 |  |   | 119.4 |  |   | 125.6 |  |
| Equity in net income of nonconsolidated affiliates                           | 1.9 |  |   | 3.0 |  |   | 10.7 |  |   | 11.2 |  |   | 12.7 |  |   | 12.0 |  |   | 10.1 |  |
| Net income attributable to noncontrolling interests in continuing operations | (15.4 | ) |   | (15.3 | ) |   | (59.7 | ) |   | (57.8 | ) |   | (50.9 | ) |   | (47.0 | ) |   | (40.9 | ) |
| Amortization of debt-related items                                           | (3.2 | ) |   | (2.0 | ) |   | (12.7 | ) |   | (5.0 | ) |   | (3.7 | ) |   | (4.2 | ) |   | (6.3 | ) |
| Distributions from nonconsolidated affiliates                                | (3.2 | ) |   | (1.8 | ) |   | (12.6 | ) |   | (11.4 | ) |   | (11.0 | ) |   | (13.0 | ) |   | (8.1 | ) |
| Current portion of income tax expense                                        | 3.5 |  |   | 3.3 |  |   | 13.3 |  |   | 6.3 |  |   | 5.9 |  |   | 0.6 |  |   | 2.9 |  |
| Change in assets and liabilities                                             | 46.4 |  |   | 27.1 |  |   | 90.1 |  |   | 48.9 |  |   | 58.1 |  |   | 41.4 |  |   | 5.7 |  |
| Net premium paid on bond issuance/redemption                                 | 10.6 |  |   | 1.7 |  |   | 4.3 |  |   | 1.7 |  |   | 1.9 |  |   | 22.8 |  |   | — |  |
| Cash used in (provided by) operating activities of discontinued operations   | 0.2 |  |   | 0.5 |  |   | 1.2 |  |   | 1.9 |  |   | (2.0 | ) |   | (9.1 | ) |   | (13.2 | ) |
| Encompass transaction costs                                                  | 9.3 |  |   | — |  |   | 9.3 |  |   | — |  |   | — |  |   | — |  |   | — |  |
| Other                                                                        | (0.3 | ) |   | 0.3 |  |   | 1.9 |  |   | 1.6 |  |   | 0.2 |  |   | 0.6 |  |   | 2.0 |  |
| Adjusted EBITDA                                                              | $ | 140.8 |  |   | $ | 142.3 |  |   | $ | 577.6 |  |   | $ | 551.6 |  |   | $ | 505.9 |  |   | $ | 466.2 |  |   | $ | 409.6 |  |

----

----

|      |                                                                                  |
|------|----------------------------------------------------------------------------------|
| 99.1 | HealthSouth Corporation Investor Reference Book - Post Q4 2014 Earnings Release. |

----

|        |
|--------|
|        |  |  |
|   |   |   |
| By:    | /S/   JOHN P. WHITTINGTON |
|   | Name: | John P. Whittington |
|   | Title: | Executive Vice President, General Counseland Corporate Secretary |